Send your comments and tips to firstname.lastname@example.org
Beth Israel Deaconess Medical Ctr.
Boston Medical Center
Brigham and Women's Hospital
Cambridge Health Alliance
Caritas St. Elizabeth's Medical Ctr.
Children's Hospital Boston
Dana-Farber Cancer Institute
Joslin Diabetes Center
Mass. General Hospital
Mass. Health Law
New England Baptist Hospital
Short White Coat
Tufts-New England Medical Center
UMass Memorial Medical Center
University of Massachusetts
VA Medical Centers
A Healthy Blog
Running A Hospital
Nature Network Boston
SciBos - Corie Lok's blog
Dr. Flea's blog
Nurse at small
Your Child's Health Blog
Healthy Children blog
Other Globe Blogs
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Boston Globe Health and Science staff:
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
Short White Coat blogger Ishani Ganguli
Wednesday, March 7, 2007
$100 million to be spent unlocking the genetic mysteries of mental illness
By Carey Goldberg, Globe Staff
It looks to be the largest single gift ever for research into mental illness: The Broad Institute, the genomics powerhouse in Cambridge, announced this evening that it will receive $100 million to figure out the genetics of schizophrenia and bipolar disorder.
It will go mainly to gather and analyze thousands of DNA samples from people with schizophrenia and bipolar disorder, in hopes of finally figuring out the complex genetics behind the diseases.
That is no easy task. The diseases afflict more than 6 million Americans, and clearly run in families. But the specific genes at work have proven largely elusive. Multiple genes are believed to be involved, and they could vary from patient to patient. Environment, too, plays a role.
But in the last year or so, gene-scanning technology has reached the point that scientists believe they can run studies on a scale large enough to detect the genetic culprits, said Dr. Edward Scolnick, who oversees the Broad's psychiatric research. He wants to gather DNA samples from as many as 10,000 people with each disease, plus 10,000 without.
That DNA then needs to be scanned in its entirety for genes correlated to the disease, and that is where the Broad's expertise comes in.
Its genomic tools have been getting ever faster and cheaper, so that it can now scan a patient's sample for half a million genetic variations at once. In a couple of months, said Eric Lander, the Broad's director, that will be up to a full million.
"If you're looking for a needle in a haystack, and you can sift the whole haystack, you'll find the needle," Lander said.
The Broad is a joint institute of Harvard University and the Massachusetts Institute of Technology.